Nanexa AB
NANEXA | ST
Overview
Corporate Details
- ISIN(s):
- SE0007074166 (+2 more)
- LEI:
- 549300J5L2ECZTLID491
- Country:
- Sweden
- Address:
- Virdings Allé 2, 754 50 Uppsala
- Website:
- https://nanexa.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Nanexa AB develops drug delivery systems based on nanotechnology. Their technology enhances the efficacy and safety of pharmaceuticals.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Medigene AG | Germany | MDG1 | |
|
MedinCell S.A. | France | MEDCL | |
|
Mendus | Sweden | IMMU | |
|
Merchavia Holdings and Investments Ltd. | Israel | MRHL | |
|
Merck KGaA | United States of America | 6MK | |
| Metabolic Nordic AB | Sweden | MBOLIC | ||
|
Modus Therapeutics Holding AB | Sweden | MODTX | |
|
Molecure S.A. | Poland | MOC | |
|
M WINKWORTH PLC | United Kingdom | WINK | |
|
Mycodern Spolka Akcyjna | Poland | MCD |